← Open Payments lookup

PAUL HEFFINGTON: Open Payments

NPI 1093087850 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,490 in 60 payments from 12 companies in 2025. Trend: 2023 $860 · 2024 $1,057 · 2025 $1,490

Food & beverage: $1,490
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.19$312
Otsuka America Pharmaceutical, Inc.9$286
Takeda Pharmaceuticals U.S.A., Inc.12$234
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$207
E.R. Squibb & Sons, L.L.C.2$144
ABBVIE INC.5$142
Neurocrine BioSciences, Inc.2$47
Lundbeck LLC2$38
Axsome Therapeutics, Inc.1$24
Alkermes, Inc.1$19

Products named: REXULTI, TRINTELLIX, CAPLYTA, UZEDY, AUSTEDO XR, COBENFY, VRAYLAR, INGREZZA.

Industry payments across SC — which companies pay providers there.